1. A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. Issue 6 (16th October 2020) Authors: Unseld, Matthias; Belic, Jelena; Pierer, Kerstin; Zhou, Qing; Moser, Tina; Bauer, Raimund; Piringer, Gudrun; Gerger, Armin; Siebenhüner, Alexander; Speicher, Michael; Heitzer, Ellen; Prager, Gerald W. Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. Issue 6 (16th October 2020) Authors: Unseld, Matthias; Belic, Jelena; Pierer, Kerstin; Zhou, Qing; Moser, Tina; Bauer, Raimund; Piringer, Gudrun; Gerger, Armin; Siebenhüner, Alexander; Speicher, Michael; Heitzer, Ellen; Prager, Gerald W. Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid. (July 2019) Authors: Kieler, Markus; Unseld, Matthias; Bianconi, Daniela; Scheithauer, Werner; Prager, Gerald W. Journal: Therapeutic advances in medical oncology Issue: Volume 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer. Issue 8 (31st July 2014) Authors: Prager, Gerald W.; Braemswig, Kira H.; Martel, Alexandra; Unseld, Matthias; Heinze, Georg; Brodowicz, Thomas; Scheithauer, Werner; Kornek, Gabriela; Zielinski, Christoph C. Journal: Cancer science Issue: Volume 105:Issue 8(2014:Aug.) Page Start: 996 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. C-reactive protein and white blood cell count are adverse prognostic markers for patients with advanced cancer on parenteral nutrition in a palliative care unit setting: A retrospective cohort study. (March 2022) Authors: Kieler, Markus; Kössler, Paul; Milovic, Matija; Meyer, Elias; Križanová, Kristína; Kum, Lea; Friedrich, Alexander; Masel, Eva; Bauer, Raimund; Unseld, Matthias Journal: Palliative medicine Issue: Volume 36:Number 3(2022) Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas: The Cancer Immunity Cycle. Issue 2 (February 2018) Authors: Kieler, Markus; Unseld, Matthias; Bianconi, Daniela; Prager, Gerald Journal: Pancreas Issue: Volume 47:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Challenges in Palliative Care Nursing at a University Hospital: A Qualitative Interview Study. Issue 5 (6th October 2022) Authors: Zeilinger, Elisabeth L.; Gabal, Ablah; Adamidis, Feroniki; Popov, Petar; Jaeger, Karin; Hufgard-Leitner, Miriam; Brettner, Robert; Titzer, Harald; Masel, Eva Katharina; Unseld, Matthias Journal: Journal of hospice and palliative nursing Issue: Volume 24:Issue 5(2022) Page Start: E219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI. Issue 4 (17th July 2019) Authors: Kieler, Markus; Unseld, Matthias; Bianconi, Daniela; Waneck, Fredrik; Mader, Robert; Wrba, Fritz; Fuereder, Thorsten; Marosi, Christine; Raderer, Markus; Staber, Philipp; Berger, Walter; Sibilia, Maria; Polterauer, Stephan; Müllauer, Leonhard; Preusser, Matthias; Zielinski, Christoph C; Prager, G... Journal: ESMO open Issue: Volume 4:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC. (August 2020) Authors: Bianconi, Daniela; Herac, Merima; Posch, Florian; Schmeidl, Margit; Unseld, Matthias; Kieler, Markus; Brettner, Robert; Müllauer, Leonhard; Riedl, Jakob; Gerger, Armin; Scheithauer, Werner; Prager, Gerald Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prevalence of pain and its association with symptoms of post‐traumatic stress disorder, depression, anxiety and distress in 846 cancer patients: A cross sectional study. Issue 4 (3rd December 2020) Authors: Unseld, Matthias; Zeilinger, Elisabeth L.; Fellinger, Matthäus; Lubowitzki, Simone; Krammer, Katharina; Nader, Ingo W.; Hafner, Matthias; Kitta, Anna; Adamidis, Feroniki; Masel, Eva K.; Preusser, Matthias; Jäger, Ulrich; Gaiger, Alexander Journal: Psycho-oncology Issue: Volume 30:Issue 4(2021) Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗